- 2013
- Press releases - 21.02.2013
COMBACTE: A new step in the fight against resistance to antibiotics
Antimicrobial resistance represents is a growing problem in public health due the increasing rarity of antibiotics capable of combating resistant bacteria. The COMBACTE project, that has just obtained 195 million euros worth of finance from the Innovative Medicines Initiative (IMI), aims to work to develop new antibiotics and introduce a successful clinical trials platform combining private and public research.
- Press releases - 21.02.2013
L’Inserm et l’Université Toulouse III – Paul Sabatier renouvellent leur partenariat
L’Inserm et l’Université Toulouse III – Paul Sabatier renouvellent leur partenariat en matière de recherche, de valorisation et de transfert de connaissances en sciences du vivant.
- Press releases - 20.02.2013
Obesity and insulin resistance: the lipolysis route
Liver and skeletal muscle resistance to the action of insulin is an early sign of the development of Type 2 Diabetes. The INSERM team at the “Obesity Research Laboratory ” in the Institut des Maladies Métaboliques and Cardiovasculaires (INSERM / Université Toulouse III – Paul Sabatier), headed by Dominique Langin, has shown through results published this week, that there is an association between lipolysis (mobilisation of fat in response to the body’s need for energy) and insulin sensitivity in humans.
- Press releases - 19.02.2013
(French) Infection VIH par voie sexuelle : élucidation de mécanismes-clé chez l’homme
The HOMAGE (Heart OMics in AGEing) project, coordinated by the French National Institute of Health and Medical Research (INSERM), has been awarded a grant by the European Commission for a 6 year period. The project aims to identify and validate specific biomarkers of heart failure in order to prevent the development of the disease affecting elderly population. 17 research groups from 10 countries will collaborate to investigate new ways of preventing heart failure. The project will use an innovative ‘omic-based’ approach which investigating simultaneously a huge amount of genes, proteins and metabolites. The 17 partners will meet at Nancy on February 22nd for the kick off meeting of HOMAGE.
- News in brief - 19.02.2013
Advances in Friedreich’s Ataxia
Friedreich’s ataxia is a rare, serious and developing neurodegenerative condition that emerges at adolescence. Those affected suffer from difficulties in coordinating voluntary movements (ataxia). This is the commonest of the hereditary ataxias of genetic origin and occurs due to a mutation of the fraxatin gene which causes a protein deficiency. The team headed by Alexandra […]
- Press releases - 18.02.2013
HOMAGE – Overcoming Heart Failure, an European challenge
The HOMAGE (Heart OMics in AGEing) project, coordinated by the French National Institute of Health and Medical Research (INSERM), has been awarded a grant by the European Commission for a 6 year period. The project aims to identify and validate specific biomarkers of heart failure in order to prevent the development of the disease affecting elderly population. 17 research groups from 10 countries will collaborate to investigate new ways of preventing heart failure. The project will use an innovative ‘omic-based’ approach which investigating simultaneously a huge amount of genes, proteins and metabolites. The 17 partners will meet at Nancy on February 22nd for the kick off meeting of HOMAGE.
- What's on? - 18.02.2013
Fertility problems – what we know and our lines of research
Infertility affects more and more couples. The data on infertility inFranceis only partial or uncertain. So we must create a fertility monitoring system, based principally on repeated, specific surveys and we must systematically include suitable questions on demographic or epidemiologic surveys used to study reproduction or contraception. It is estimated that around 15% to 20% […]
- Press releases - 15.02.2013
History of stroke and coronary heart disease – a fatal combination
The cardiology service team at the Hôpital Bichat and the Mixed INSERM Unit 698 (AP-HP, Université Paris Diderot), in collaboration with international teams of researchers, studied a cohort of patients suffering from coronary disease. The study showed that those patients with a history of stroke or transient ischæmic attack (TIA) are not only at higher risk of cardio-vascular episodes but also of haemorrhagic events, stressing the therapeutic challenge involved in treating such patients.
- Press releases - 13.02.2013
The efficacy of certain anti-cancer vaccines depends on how they are administered
The therapeutic efficacy of certain anti-cancer vaccines depends on how they are administered. This is what the team of researchers headed by Eric Tartour at the Paris-Centre de recherche Cardiovasculaire (Université Paris Descartes, INSERM Unit 970 PARCC, AP-HP), in collaboration with researchers from the CNRS , have just demonstrated.
- Press releases - 13.02.2013
“Simplified” brain lets the iCub robot learn language
The iCub humanoid robot on which the team directed by Peter Ford Dominey, CNRS Director of Research at Inserm Unit 846 known as the “Institut pour les cellules souches et cerveau de Lyon” [Lyon Institute for Stem Cell and Brain Research] (Inserm, CNRS, Université Claude Bernard Lyon 1) has been working for many years will now be able to understand what is being said to it and even anticipate the end of a sentence. This technological prowess was made possible by the development of a “simplified artificial brain” that reproduces certain types of so-called “recurrent” connections observed in the human brain.